Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood Coagul Fibrinolysis ; 23(5): 402-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22527291

ABSTRACT

Obesity is characterized by alterations in haemostatic processes that lead to a prothrombotic state. D-dimer (D-Di) is the last product of the fibrinolysis and may reflect the haemostatic balance. As the plasminogen activator inhibitor (PAI)-1 is the main inhibitor of fibrinolysis and it is elevated in obese, we hypothesize that negative correlation exists between PAI-1 and D-Di. In addition, we evaluated if plasma levels of PAI-1 and D-Di may be correlated with clinical parameters of adiposity [waist circumference and waist-to-hip ratio (WHR)]. We measured plasma PAI-1 and D-Di concentrations using ELISA in 60 women: 21 lean women without comorbidities and 39 obese women. We found higher levels of D-Di and PAI-1 in obese groups compared to control group (P < 0.05). No differences were observed between obese and obese untreated hypertensives. PAI-1 levels, but not of D-Di, are positively correlated with BMI (control, r = 0.44) and WHR (all obese, r = 0.40). Negative correlation was found between PAI-1 and D-Di in control (r = -0.56), no association was observed in obese, signalizing to a particular attention regarding the clinical use of D-Di. Our results indicate the magnitude of central obesity as a risk factor for development of disorders related to prothrombotic states.


Subject(s)
Fibrin Fibrinogen Degradation Products/analysis , Obesity/blood , Plasminogen Activator Inhibitor 1/blood , Adult , Analysis of Variance , Biomarkers/blood , Body Mass Index , Female , Fibrinolysis/physiology , Humans , Middle Aged , Risk Factors , Waist Circumference , Waist-Hip Ratio
2.
Clin Biochem ; 45(6): 412-5, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22285381

ABSTRACT

OBJECTIVES: To compare the plasma concentrations of matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-1, MMP-8, and myeloperoxidase (MPO) for obese and lean women. DESIGN AND METHODS: We recruited 30 lean and 36 obese women without comorbidities. The MMP-9, TIMP-1, and MMP-8 levels were measured using enzyme-linked immunosorbent assay (ELISA). MPO activity was assessed by a colorimetric assay. RESULTS: Obese women had higher MMP-9 levels and MMP-9:TIMP-1 ratios than lean women. Conversely, the MMP-8 levels and MMP-8:TIMP-1 ratios in the obese women were significantly lower than those in the lean women despite neutrophil activation, which was assessed by MPO activity. CONCLUSION: We observed that MMP-9 and MMP-8 had distinct profiles, which suggested that these 2 enzymes play different roles in obesity.


Subject(s)
Matrix Metalloproteinase 8/blood , Matrix Metalloproteinase 9/blood , Obesity/blood , Peroxidase/blood , Thinness/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Adult , Female , Humans , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...